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The subject of this paper is long range planning or policy development for healthcare in the
Netherlands. Especially the co-ordinating function of planning will be discussed. In healthcare
different actors or stakeholders are involved. Each of these actors may have their own interests,
expectations, goals, and knowledge. The main goal of this paper is to discuss the alleged
centralisation versus decentralisation dichotomy in healthcare strategic decision making and
planning. The development of facilities for radiotherapy is used as an exemplary case for this
explorative research. The radiotherapy case illustrates that a more centralised, comprehensive, and
systemic way of planning and strategic decision making might be necessary to take into account
and balance the different developments, which are relevant for this specific problem field, at the
macro level. This kind of strategic process involves inputs from medical specialists and other
experts with various disciplinary backgrounds. All relevant knowledge regarding facts and trends
on demographic, social, epidemiological, technological, and therapeutic factors, and also those
concerning the basic disciplines (such as biology) should be collected and analysed to obtain the
insights needed. This expertise can not be found on a local or even regional level. It requires
initiatives from co-ordinating boards like the Health Council, but also professional bodies play an
important role, next to initiatives from influential and respected individuals.
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In the Netherlands, policy development, co-ordination, and decision making in the field
of healthcare could be characterised as highly centralised. The Ministry of Healthcare and
its advisory boards: The Health Council (“Gezondheidsraad”), the Council for Hospital
Facilities (“College voor Ziekenhuisvoorzieningen”), the Dutch Sickfund Council
(former “Ziekenfondsraad”), and the organisations of general practitioners and medical
specialists were the main actors. They operated primarily on the macro-level. Strategic
initiatives were, however, usually taken in hospitals and regional co-operative bodies, on
the micro and meso level. The roles of the national government and its advisory bodies
were mainly defined by an institutional legal context (esp. article 18 of the Law for
Hospital Facilities should be mentioned)1 and confined by macro-economic conditions.
The responsibility of the Health Council is enacted by law. Its mission is to report
to the government on the state of medicine and its consequences for the healthcare
system. In practice, this council explores, forecasts, evaluates, and assesses specific new
developments on their meaning and consequences for the healthcare system. Generally,
these activities result in strategic outlooks and capacity plans for certain specialisms or
functions of the healthcare system nation wide. The Council for Hospital Facilities has
the function to test if certain individual initiatives of hospitals fit into the national
capacity plans (for instance regarding numbers of beds), to test if they comply to
conditions of efficiency, and to verify certain legal conditions. The (former) Dutch
Sickfund Council has a function in the nation wide assessment of the costs and effects of
existing and new medical technology. In the early nineties the roles of these main actors
in policy development changed. This was partly caused by the emerging idea that cost
containment in healthcare could be better realised by decentralisation, privatisation, and
concomitant enhancement of the market function.
The continuous escalation of healthcare costs (in absolute numbers) during the
seventies, eighties and nineties is mainly a consequence of the growth in the need for and
supply of medical and related services. This growth is caused by a complexity of factors:
3ageing of the population, increasing consumerism and growing expectations of patients
about the possibilities of modern medicine, reinforced by the development, introduction,
and marketing of new medical technologies and drugs (c.f. Mooney, 1994; Dunning et al.,
1997). In order to realise cost containment, the Dutch government wants to act primarily
as financier (for not insurable healthcare costs), and as price and budget regulator. Its
main objective is maintaining a macro-economic goal: the healthcare budget should not
exceed (about) 8% of the Gross National Product. The basic idea behind this policy is that
the parties involved in healthcare delivery should also be responsible for the
implementation of healthcare policy (and strategies). Insurance companies, medical
specialists and their professional societies, and hospital management should negotiate and
come to agreements within the conditions set by the government. In that way these -
mostly - regional and local organised market-parties are assumed to be responsible for
their strategic decisions and actions. Cost reductions are supposed to be the responsibility
of the market-parties themselves. In this market-oriented view on healthcare, a more
decentralised way of decision making and co-ordination is stressed (c.f. Coalition
Agreement Dutch Government, 1994). One can observe that the emphasis shifted in this
way from a centralised to a more decentralised point of view on policy development. The
primary goal for healthcare remains an economic one, realising cost containment and, if
possible, cost reduction in healthcare. The rationale behind this policy is also fed by the
idea to maintain the prices of the Dutch products and services competitive on the
international market. The level of wages is partly determined by the costs of healthcare,
as a result of the way the healthcare system is financed in the Netherlands. It is, however,
questionable if this ‘paradigm of competition’ really contributes to macro economic
goals. There are situations in healthcare in which policy making cannot be performed
effectively on the hospital or on the regional level. Because of the interaction between
activities, developments, and capacities, a more centrally directed policy development on
a higher level (both top down and bottom-up) may be preferred. Especially the
assessment of the needs for healthcare facilities with relatively long development periods
4and relatively high investments in capital-intensive assets and training may be best
performed for a total population on a centralised basis. In that case, a more systematic
and holistic approach for the assessment and the balancing of capacity needs and
investments is necessary for matching the demands of the population, and for the best use
of scarce resources. The interests of individual hospitals and other actors in the policy
development can be more effectively matched and co-ordinated by an analysis of
epidemiological, demographic, technological, and medical developments on a nation
wide level, within an European context. This makes the gathering, analysing, combining
and balancing of specific information on the various factors involved necessary. Leaving
such an assessment of capacity needs together with allocation decisions, to the ‘market
mechanism’ may lead to different kinds of misfits (too much capacity resulting in under-
utilisation or the opposite resulting in waiting lists) and a waste of scarce resources.
The main goal of this paper is to address the seemingly dichotomy between a
centrally directed and a more decentralised (market level) strategic decision making and
co-ordination of the allocation and development of facilities in the healthcare sector. This
discussion will be illustrated by making use of an exemplary case: the long term planning
and decision making of facilities on behalf of radiotherapy in the Netherlands. By
choosing this case, also some arguments for the value added of the so-called Dutch
‘Poldermodel’ are presented (c.f. Van Witteloostuijn, 1999).
This paper reflects explorative research and is not based on empirical testing.
When in the following the word planning is used, it must be interpreted in the meaning of
its co-ordinating function (Alexander, 1992). The choice for the case of radiotherapy is
made, because of the fact that the policies regarding this subject are relatively well
developed and documented. Moreover, in the last two decades in different developed
countries (especially in Australia, the Netherlands, and Sweden) committees manned by
leading professionals have developed consensus concerning a set of normative indicators
for the use of radiotherapy. These indicators are based on data from clinical empirical
5research and cancer registries.  They enable needs assessment and capacity planning in a
more comprehensive way and on a higher level than before.
In the next section, a few general dimensions of strategic decision making in
healthcare are discussed. Subsequently, the case of radiotherapy is elaborated.
Radiotherapy is one of the main modalities for the treatment of cancer, besides surgery
and chemotherapy. A substantial part of the patients is treated by a combination of these
modalities. Because of this, an outline is given of the care for cancer patients with its
main diagnostic and treatment modalities and their mutual relationships. Also, a short
overview of the history of the development of facilities for radiotherapy and its
infrastructure in the Netherlands is presented. Next, capacity planning and allocation in
this policy field are discussed. A capacity model is presented and its use for the
development of a set of scenarios is demonstrated. This paper ends with some
considerations related to this case, a discussion, and concluding remarks.
6WUDWHJLFSODQQLQJDQGGHFLVLRQPDNLQJLQKHDOWKFDUH
Strategic decisions are generally characterised by their high impact on the continuity of
the whole or on important parts of an organisation or system; they have a high degree of
uncertainty and/or are taken under partial ignorance about their consequences; they are
focused on the long term direction; they are likely to be concerned with the scope of an
organisation’s activities, and finally, the idea that generally strategic decisions are mainly
taken by the top management is also seen as a characteristic of strategic planning (c.f.
Johnson and Scholes, 1997; Wheelen and Hunger, 2000). There are differences between
strategic decision making in healthcare and the general characteristics mentioned, which
reflect the situation in large machine organisations. In the healthcare system there is often
not one body or one integrated system of decision making which determines the whole
system (c.f. Mintzberg, 1989). In general, the actors in the healthcare system are
professional bureaucracies. Strategic initiatives and decisions regarding the primary
6processes within these organisations are taken at the level of the medical professionals in
hospitals, in their societies or at an international level by the peers of their scientific
communities. There are other strategic problems, initiated by other stakeholders on other
levels in healthcare (examples are the initiatives and decisions to merge between hospitals
and to construct new hospital buildings). These decisions are often initiated at the level of
hospital boards, owners of hospitals or sometimes at the governmental level.
The various levels in strategic decision making or policy setting in the healthcare
system are presented in table 1. We use as an example the field of cancer care with its
large variety of organisations and stakeholders to show the potential complexity (c.f.
Duncan et al., 1998).
7Table 1 : Levels of policy and decision making in healthcare
Levels Organisations Examples
1. International World wide - World Health Organisation
- Leading centres in science and development
- International Agency for Research on  Cancer
European - European Organisation for Research and Treatment of
   Cancer
- European Association for Cancer Research
2. National Parliament - Different political parties
- Parliamentary Commissions
Government - Department of Healthcare
- Council for Hospital Facilities
Professional organisations - Royal Dutch  Medical Association
- Dutch Society for Radiotherapists
Charity - Dutch Cancer Foundation (KWF)
Advisory boards - Health Council
- Dutch Sickfund Council
Insurance companies - Nation wide: FBTO
- Regional: Univé
3. Regional Comprehensive cancer centres - Integral Cancer Centre for the Northern part of the
Netherlands.
Regional authorities - SOOZ (Co-operation in the South-eastern part of the
Netherlands between hospitals)
4. Local Hospitals with sub-specialisation
on the care for cancer patients
- Academic hospitals
- General hospitals
- Specialised oncology institutes (e.g. National Cancer
Institute)
Hospital departments - Radiotherapy departments or institutes for radiotherapy
- Internal medicine sub-specialised in oncology
- Surgery sub-specialised in oncology
- Gynaecology sub-specialised in oncology
- Urology
-----------------
Practices of radiotherapy - Legal partnerships of radiotherapists
- Radiotherapists as employees of hospitals
General practitioners - Individual
- Organised in group practices
8On each of these levels strategic planning and decision making can be initiated and
performed (see also Lindblom, 1980). There is a complex of factors which determines
these decisions in healthcare. The most important are demographic, epidemiological,
scientific and technological, economic, payment systems, and influences of lifestyles.
Each change in one or more of these factors will have consequences for the formulation
of strategies and their implementation, on the levels mentioned in table 1. When there is
no coherence in the policy development between and within the different levels, the
conflicting interest of the stakeholders can cause a waste of scarce resources. For
instance, initiatives leading to a doubling of the capacities for radiotherapy in a certain
hospital can spill over to the region and eventually also to the national capacity in this
field, when they are not adapted to the needs of the population as a whole.
Also, when existing consensus on the use of radiotherapy in the leading institutes of
the world changes, resulting into new insights on a national level, this will consecutively
have consequences for the local level. Such changes, for instance resulting in broadening
the indications for treatment, may cause shortages in capacities: in equipment, radio-
therapists, paramedics and result in waiting lists.(c.f. Leer, 1999). One may conclude
from this example that strategic planning in the healthcare sector involves multi-level and
multi-actor decision making and when there is no coherence between them, it may lead to
a waste of scarce resources or a shortage of capacities. In this respect, we distinguish the
following relevant dimensions of strategic decision making and co-ordination in
healthcare:
- Kind of decision: the determination of needs (quantities) and the allocation (where)
of medical facilities.
- Level of decision: centralised ((inter) national level) or decentralised (local/hospital
and/or regional level).
- Initiatives for decision making process:
Top down:
9- From ministry/advisory board levels to hospital boards (for instance
initiatives may pop up at the level of the Ministry of health proposing actions
to resolve waiting lists)
- Within institutions (for instance from hospital board of directors to the
medical professionals)
Bottom-up:
- Within institutions (for instance initiatives to introduce new medical
technology from the professionals to the hospital level)
- From hospital boards to the level of Ministry/advisory boards
The open boundaries between private and public actors in the healthcare domain suggest
various relationships between them. The determination of needs for care and the facilities
needed for a total population asks for the interaction between the different levels. It may
be best performed on basis of a centralised system for co-ordination and decision making.
The main reason for this is the need for a more systematic and holistic point of view in
this situation. Such a vision should be developed by representatives of the different
scientific and professional disciplines involved, and to be used for the assessment of the
initiatives in the individual hospitals. In essence, this entails a multidisciplinary approach.
In this way the needs of the population for specific care and the initiatives taken can be
matched with initiatives in the individual hospitals. This requires both top down and
bottom-up initiatives. These forms of co-ordination include associations, federations, or
other co-operative frameworks and may be governed by bodies such as commissions,
boards, or task forces representing the various involved interests (Alexander, 1992).
Although the co-ordination by these bodies result from interaction, consultation, or
negotiation of various stakeholders/parties, ultimately, the Minister of Healthcare
authorises the resulting plans or decides by means of so-called planning decrees
(“planningsbesluiten”). In this respect the Minister is decision maker of last resort.
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In the developed countries cancer is a serious public health problem (SBU, 1997). This is
primarily due to the high life expectancy, wealth, and life styles. In the Netherlands, it is
the second cause of death next to mortality caused by cardio-, and cerebro-vascular
diseases (SCC, 1999). Generally, a general practitioner may be the first person to indicate
that cancer might be a cause of pain, general illness or misery. The patient subsequently
will be referred to a hospital, were cancer as such can be diagnosed. In general,
depending on the kind of tumour and its stage and location, cancer can be treated with
three modalities: surgery by specialists from all surgical disciplines (surgical specialists,
urologists, gynaecologists, neurosurgeons, etc.), chemotherapy (specialists from internal
medicine, paediatricians, etc.), or radiotherapy (radiotherapists), or with a combination of
these modalities. Between 40-50% of the patients in the Netherlands is treated with
radiotherapy, whether or not in combination with one or more other modalities. So,
investments in facilities for radiotherapy have a major impact on the possibilities for
treatment of cancer patients and have a great strategic impact on the care they need.
Medical care for cancer patients, regarding diagnosis and treatment of their tumours is
mainly performed by medical specialists and is characterised by a large variety of (sub-)
specialisation. The processes of developing standards for diagnosis and treatment, the
nursing care for cancer patients, and consultation from the sub-specialisation to the
generalist level are in the Netherlands co-ordinated by regionally organised compre-
hensive cancer centres. These organisations can be typified as network organisations2.
As stated in the introduction of this paper, the process of policy development, co-
ordination, and decision making regarding radiotherapy is used as an exemplary case. We
present a closer look on what radiotherapy is and its specific contribution to the care for
cancer patients. The objective of radiotherapy is to deliver a defined radiation dose to a
specific place in or on the body with the intent to kill tumour cells while minimising
irradiation damage of surrounding, healthy tissue. An array of equipment is needed to
perform this task: imaging equipment (such as CT-scanners, Magnetic Resonance
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Imaging, ultrasound-devices, and nuclear medicine) used for localisation and treatment
planning, equipment for treatment (linear accelerators, after-loading devices, and fixation
devices). Equipment for radiotherapy asks for special facilities: buildings (radiation
shielding) and specialised human resources (radiotherapists, clinical physicists and
paramedics). Linear accelerators used for mega-voltage therapy are the most important
elements of equipment for treatment. About 95% of all the patients for whom
radiotherapy is indicated are treated with one or other type of linear accelerator. The
treatment facilities and capital investments in this respect are substantial, necessitating
long term planning for building up capacities in equipment and manpower.
As in most industrialised countries, in the Netherlands, radiotherapy is involved
in about 50% of all treatments of cancer patients (De Jong et al., 1994; Van Daal and Bos,
1997). In 1995, about 63,000 invasive tumours (males: 33,000 and females: 30,000) were
registered in 57,000 new patients, in that same year about 36.500 people died of cancer
(VIK, 1998).  The incidence of cancer (the number of new patients per year), for all types
of cancer, is steady (SCC, 1999: 110). Cancer is a disease that is age-related (70% of all
new patients over 60 years). Its prevalence (number of existing patients per year) is very
sensitive to demographic trends and geographic variations. Most cancer patients receive
more than once during their illness radiation therapy with megavoltage equipment.
In Sweden, radiotherapy accounts for about 5% of the total costs for treating
cancer patients (SBU, 1997). This is about $50 mln. For the EU the average costs per
treatment of radiotherapy is about 3000 ECU, for surgery it is about 7000 ECU and for
internal medicine about 17000 ECU (Van Daal and Bos, 1997). In the Netherlands, the
costs for radiotherapy are expected to be in the same order of magnitude3. However,
AHTAC (1997) in their meta-study state the following: “The costs and cost effectiveness
of radiotherapy, surgery and chemotherapy in the treatment of cancer are not very well
documented”. Moreover, AHTAC concludes that “costing methodologies vary signifi-
cantly from study to study, and it is therefore not possible to accurately compare the costs
12
of radiotherapy with those of other modalities” (p.43). Besides this, the complementarity
of the different treatment modalities is also a complicating factor in such studies.
3ODQQLQJIRUUDGLRWKHUDS\IDFLOLWLHVLQWKH1HWKHUODQGVDVKRUWRYHUYLHZ
In the Netherlands, a tradition exists in anticipating and planning for radiotherapy
facilities on the national level (this is partly a result of institutional measures, see also the
introduction). In 1974 the Health Council published its first report on the use of
radiotherapy. This report already showed the relation between the growing number of
(expected) cancer patients and corresponding healthcare demands in this respect. In 1984
the Health Council published its second report on radiotherapy, including a (first)
discussion about the future development of radiotherapy capacity (HC, 1984). This report
indicated a capacity shortage at that moment and a growing shortage in the near future.
This report was the first structured attempt to assess and analyse the Dutch radiotherapy
usage from different (multidisciplinary) points of view and to forecast technological,
medical, demographic, and other relevant developments in the field of radiotherapy and
their consequences for the radiotherapy infrastructure (c.f. Postma, 1989). In 1987 the
National Scenario Committee on Cancer published its report underlining the main
conclusions of the Health Council, it also provided an outlook on the long term of the
cancer problem in the Netherlands. This resulted in a policy document for the government
(especially Ministry of Health) that presented a capacity-assessment for the period until
1995 and a plan containing the diffusion of radiotherapy facilities across the country. This
plan accounted for an increase of facilities of almost 50% in 1995. In 1993, the Health
Council published its final report on radiotherapy facilities. This report (HC, 1993)
contained an assessment of the need for radiotherapy facilities and two scenarios, called
the reference scenario and the quality scenario, indicating the possible development of the
need for radiotherapy capacity for the period 1995-2010. Until recently, the national
Scenario Committee on Cancer (from 1997 on called Signalling Committee on Cancer5)
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has published, on a regular basis, reports signalling the relevant trends in the field of
cancer. The Council of Hospital Facilities acted in this period within the context of article
18 of the Law of Hospital Facilities to translate these plans into detailed capacity plans
and tested initiatives of individual hospitals on their relevance and efficiency within the
conditions of these plans. In general, the composition and quality of the various
committees were of eminent importance for the quality and acceptability of their advisory
outputs.
In the due course of these years consensus has been reached about a planning
model with which the capacity-needs for radiotherapy on the national level can be
forecasted. This model is developed by the input of numerous parties (Health Council,
Ministry of Health, the professional body of radiotherapists, the Scenario Committee on
Cancer, and many individuals, see table 1). The model boils down to a set of driving
forces that determines the need for the capacity and the structure of radiotherapy
facilities. The most important driving force in this system is the number of expected
cancer patients in need for radiotherapy. Based on that, the number of patients eligible for
radiotherapy can be calculated and the capacity that is needed to treat these patients. In
this respect international differences show up, see table 2:




Australia 1995 39 AHTAC (1997)
Canada 1987 54 SBU (1997)
The Neth/
 SOOZ-area6
1975-1989 56 De Jong et al. (1994)
Great Britain 1979 53 (SBU (1997)
Sweden 1992 30-33 (SBU (1997)
USA 1990 57 (SBU (1997)
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Radiotherapy in Sweden is a less utilised treatment modality (SBU, 1997: 90) compared
to other developed countries. These figures are sometimes based on surveys, sometimes
on subjective estimates. In general, however, they must be considered with care.
Differences between countries may be a consequence of differences in the availability of
and/or access to modern screening, diagnostic, and treatment facilities (c.f. Berrino et al.,
1998). International variations in the application of radiotherapy may be a consequence of
different definitions of new patients, demographic differences, differences in access to
care, and diverging referral and treatment policies (De Jong et al., 1994). This
complicates international comparisons and leads to the conclusion that long range
planning of these kinds of facilities might be best done at the national level. Pro-active
national planning–initiatives (such as AHTAC, SBU and Dutch Health Council) are
therefore the best way to proceed. Although, of course international co-ordination-efforts
on the level of for instance the European Community or European Organisation for
Research and Treatment of Cancer, international contacts between radiotherapists,
radiophysicists, and other disciplines involved are needed and must be stimulated.
Learning in policy development, based on the exchange of international experiences, will
then be accommodated and possibly accelerated.
Besides differences between countries, there can also be considerable regional
differences within a country. For instance, De Jong et al. (1994) discuss demand and
supply (differences) in the south-eastern part of the Netherlands. They indicate that the
number of cancer patients amenable to radiotherapy may increase, because of the
presence of more and better-trained referring specialists or general practitioners. Also, the
development of radiation treatment guidelines, the existence of a comprehensive cancer
centre and/or an academic setting can influence the supply and demand of radiotherapy
facilities in specific regions. Moreover, referral-patterns vary according to the different
cancer sites. Some cancer patients can be treated very well in a local hospital, under the
guidance of cancer consultants in the context of a comprehensive cancer centre (e.g.
patients with prostate cancer). Patients with more rare or complicated forms of cancer and
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or possibilities for curation should be referred to a specialised cancer centre in (e.g.
patients with Hodgkin’s disease). However, one may observe that guidelines for referral
and treatment are not always systematically and consistently applied. In this respect,
catchment areas of hospitals are ambiguously defined. Finally, the life-styles and working
conditions that are prevalent in a region can affect the demand for radiotherapy7.
Summing up, differences in this way can lead to considerable different patterns of
capacity need and capacity usage within a country.
This means that capacity-decisions regarding the need of facilities on a regional
or hospital level can lead to under- or over-estimations. The specific interests of medical
specialists and hospital management may play a role in this discussion. More centrally
directed decision making and co-ordination could prevent or mitigate such sub-optimal
strategic behaviour. The choice of the strategic decision making level is therefore
important for the development and use of a capacity- or needs model.
A national capacity (needs) model in the field of radiotherapy must take into account
the following:
- The causes of cancer and the distribution of cancer in the population.
- The medical views and guidelines (protocols) about radiotherapy treatment
(indications).
- The specific modalities and equipment to diagnose and to treat patients (and
developments these).
The capacity/needs model will be developed and elaborated in the next sections.
$VVHVVPHQWRIWKHQHHGIRUUDGLRWKHUDS\IDFLOLWLHV
In this section a capacity model will be explicated that can be used for the determination
of the needs for radiotherapy-facilities on the long term. The capacity model contains the
following variables and relationships:
16
- The annual number of new cancer patients is determined by demography
(composition, size of the population, and geographic variations); epidemiology
(incidence: gender, age-group, types of tumour); and finally the technological
developments influencing the possibilities of cancer treatment (e.g. the development
in irradiation treatment equipment or drug application).
- The number of cancer patients that is eligible for treatment with radiotherapy can be
calculated as a percentage of the total number of new cancer patients a year.
Subsequently, this number must be corrected for the fact that a fraction of these
patients will have more than one treatment per year, also some of the patients develop
cancer again in a later stadium in their lives and will therefore receive additional
irradiation treatment. The number of cancer patients that will be treated with
megavoltage equipment is a fraction of this number of radiotherapy patients.
- If the number of radiotherapy patients is calculated the needed capacity (manpower
and megavoltage units) can be determined, by using certain norms (established in
committees of experts) of numbers of patients treated by radiotherapists and
radiophysicists, and norms (standard figures) of sessions per treatment, and based on
that calculation the total treatment sessions (leading to the needed number of
megavoltage units and radiotherapy technicians). For a more detailed account of
these variables and relationships, we refer to annex 1.
In figure 1 this model is presented in a graphical way. This figure also shows the
interactions between the different boxes.
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Figure 1 : Simplified capacity/needs model radiotherapy
This figure shows the most elementary variables and relationships between these
variables. The model can of course be more refined (see annex 1). The variables and





New and recurrent patients
New radiotherapy patients
Number of radiotherapists Number of radiophysicists Number of radiotherapytechnicians Number of linear accelerators
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Daal and Bos, 1997). The most recent variables and their parameter values are presented
in table 3:
Table 3: Variables and parameter values for the Dutch situation based on most recent
sources




40 % (De Jong et al., 1994)
Percentage of recurrence
of radiotherapy patients
40 % (De Jong et al., 1994)
Workload radiotherapist












(annual no. of sessions
per patient)






Based on the capacity/needs model and the parameter values, scenarios can be developed
to support long range decision making, planning and development of an infrastructure for
radiotherapy.
19
Multiple scenario analysis is praised for the radically different stance it takes towards
environmental uncertainties (Van der Heijden, 1996). Whereas trend projecting
forecasting techniques try to abandon any uncertainty by providing managers with only
one forecast, multiple scenario analysis deliberately confronts managers with
environmental uncertainties by presenting them several fundamentally different outlooks
on the future (Schoemaker and Van der Heijden, 1992; Wack, 1985). Generally, a
scenario depicts some feasible future state of an organisation’s environment and mostly
includes the dynamic sequence of interacting events, conditions and changes that is
necessary to reach that state (e.g., Raubitschek, 1988). According to Kahn and Wiener
(1967), two pioneers within the area of scenario analysis, scenarios focus attention on
causal processes and crucial decision points. In doing so, scenarios highlight fundamental
uncertainties surrounding the (strategic) decisions managers have to make. The scenario
method is a suitable method to handle a few uncertainties in the environment. In
healthcare, and especially the field of radiotherapy, the gradually and simultaneous
changing of many factors (in a more or less predetermined direction), combined with a
few key driving uncertain forces, which interact with each other, underlines the choice for
this method. A complicating factor in healthcare, however, is that the external and
uncertain environment partly can be influenced by actors in healthcare itself. For instance
the demographic changes are partly caused by the healthcare system itself.
6FHQDULRGHYHORSPHQWIRUUDGLRWKHUDS\IDFLOLWLHV
Based on the most recent source on demography (of the Dutch Central Bureau of
Statistics; CBS, 1999), a group of scenarios with different demographic expectations
(low, medium, and high variant) is constructed. The medium variant describes the
average expected future development of the Dutch population. The low and high variants
correspond with the limits of a 67%-forecast interval of population size. In other words, it
is assumed that the probability is 67% that this interval will include the true population
20
size in a given forecast year (CBS, 1999: 66). Next, the incidence (annual number of new
cancer patients per age-group and gender) is determined by using the data of the
Netherlands Cancer Registry (VIK, 1998). The resulting group of, what is called the,
reference scenarios is based on the most recent Dutch sources and varies according to the
three demographic variants. These scenarios show the effects of different assumptions
regarding to the development of the Dutch population on the number of expected cancer
patients eligible for radiotherapy and the capacity consequences of these numbers of
patients.
Table 4 : Three population scenarios: low, medium, and high population variants
transformed into expected numbers of cancer patients and numbers of radiotherapy
patients (NCP = New Cancer Patients; RP = Radiotherapy Patients)
3DWLHQWV 6FHQ       
NCP L 60500 62400 72700 85300 95700 98900 95100
M 60500 62500 74100 88100 100500 105600 103800
H 60500 62600 75400 91000 105300 112800 113300
RP L 33800 34900 40600 47600 53500 55200 53400
M 33800 34900 41400 49200 56100 59000 58000
H 33800 35000 42100 50800 58800 63000 63300
These numbers of radiotherapy patients can be subsequently used for the calculation of
numbers of needed manpower and linear accelerators. See table 5.
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Table 5 : Needed capacity for radiotherapy services (Rth = Radiotherapists; Rph =
Radiotherapy physicists; Rte = radiotherapy technicians; LA = Linear Accelerators)
&DSDFLW\ 6FHQ       
Rth L 142 147 171 201 225 233 225
M 142 147 174 207 236 248 244
H 142 147 177 214 248 265 266
Rph L 62 64 74 87 89 101 98
M 62 64 76 90 103 108 106
H 62 64 77 93 108 115 116
Rte L 591 610 710 833 935 966 934
M 591 611 724 860 9828 1031 1014
H 591 612 737 889 1028 1101 1106
LA L 68 70 81 95 107 110 107
M 68 70 83 98 112 118 116
H 68 70 84 102 118 126 127
Subsequently, by using only the medium population variants, other scenarios can be
derived. In table 6 the consequences are shown if the percentage of referrals of cancer
patients eligible for radiotherapy rises from 40% to 50%.
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Table 6 : Consequences for capacity needs as a result of changing the percentage of
referrals to radiotherapy as a treatment modality from 40% to 50%
&DSDFLW\ 6FHQ       
Rth M  178  184  218  259  296  310  305
Rph M  77  80  95 113  128  135  133
Rte M  739 763  904  1075  1227  1289  1268
LA M  85  87 103  123  140  147  145
Table 6 shows that if the referral patterns for radiotherapy increase to an internationally
recognised level of 50%, this has serious implications for the needed capacity of
radiotherapy facilities. One can also introduce different approaches in radiotherapy, for
example more individualised treatment methods, a higher level of quality assurance and
so on. Sensitivity analyses on other variables are of course possible. The complexity
increases substantially when the various parameter-values all change at the same time. As
an input for the strategic decision making and planning process, the results of scenario-
planning can be used to enhance strategic learning and the strategic conversation (Bood
and Postma, 1997; Van der Heijden, 1996).
&RQVLGHUDWLRQVEDVHGRQWKH’XWFKUDGLRWKHUDS\FDVH
In section 2 the various dimensions of strategic decision making planning are discussed,
the following remarks can be made:
- The scenarios in section 6 are made with respect to the support of (long term)
strategic decisions concerning the needs for radiotherapy facilities (and not the
allocation of these facilities) on a population basis.
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- These decisions (and their initiatives) involve strategic decision makers at different
decision making and planning (esp. centralised) levels. The strategic process involves
inputs from specialists and experts with various disciplinary backgrounds. All
available knowledge on a national or international wide scale must be used to collect
and analyse the needed insights regarding facts and trends into demographic, social,
epidemiological, and therapeutic factors, and also those in the basic disciplines (such
as biology, chemistry). The needed expertise can not be found on a local or even
regional level. This must be organised on the (inter) national level. It requires
initiatives from co-ordinating boards like the Health Council, but also professional
bodies play an important role, next to initiatives from influential and respected
individuals. The input of regional and hospital level data is, however, necessary to
plan effectively at the central level. Patient registries can play a significant role as an
information provider.
- For the determination of the need of facilities on a population basis, the market as a
co-ordinating system can not always offer the optimal solution, especially in cases in
which individual hospitals function in the context of an oligopolistic market and
relatively inelastic demand conditions.
- The main advantage of centralised strategic decision making is that during the
decision making process, problem solving activities are developed, and that all
relevant actors participate in the decision making process and have in principle equal
access to the same information. In this way the ‘garbage can’ (March and Olsen,
1976) of this decision making and co-ordination problem has been made more
transparant and structured.8
A problem related to centralised decision making and co-ordination, however, is the
aggregation problem (Bosman, 1977). This means that by aggregating data the possibility
exists that detailed differences concerning micro-data on certain referral patterns,
demographic trends, availability of facilities, available knowledge of medical specialists
and patients, etc. are levelled out. However, it remains questionable if decentralised
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decision making and planning of facilities as the alternative solution (as seems to be
considered as the best solution to cost containment in the Netherlands) is the best way of
proceeding. The case of radiotherapy suggests that it has the risk of arriving at sub-
optimal solutions (from a macro point of view), based on the possible casual convergence
of these same factors.
’LVFXVVLRQDQGFRQFOXGLQJUHPDUNV
We are aware of the potential drawbacks of centralised decision making and planning.
Too much centralised directed co-ordination may possibly result in Soviet kinds of
planning (see footnote 8). Also, Mintzberg (1994) reminded us of the potential negative
side-effects of centralised strategic planning. Nevertheless, what we mean by more co-
ordinated planning and decision making is not the same as more formalisation, regulation,
and centralised healthcare production agreements. We would like to stress more the
eclectic function of bringing together experts, information, and knowledge from various
backgrounds and disciplines and integrating this explicitly in the policy and decision
making processes (both nationally and institutionally).
The question ‘which hospital needs what facilities’ (the allocation question) is not
discussed in this paper. The co-ordination of the nation-wide allocation of the needed
facilities is a different story. It depends on local/regional circumstances. The market as a
co-ordinating mechanism may be suitable in this case. The allocation of radiotherapy
facilities on a regional or hospital basis to meet the expected demand and to optimise the
supply of services should take into account the following consequences:
- “Economies of scale” can be realised by concentration of facilities (equipment and
manpower). This may result in a more efficient and cost-effective input and use of
resources. In general, a certain minimum level of facilities is necessary, because of
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operational conditions (think of full utilisation of capacity, maintenance of
equipment, training of personnel, learning curve-effects).
- “Economies of scope” can be realised because of the complimentarity of radiotherapy
as a treatment modality with other treatment modalities The combination with other
modalities (surgery and chemotherapy) asks for a hospital infrastructure in which a
certain minimal level of knowledge and diagnostic and therapeutic equipment is
present. Also joint diagnosis and treatment of patients may based on sub-
specialisation offer advantages, next to the potential positive effects of spill-over of
knowledge to other disciplines.
- In-depth knowledge is necessary for planners about the content of this policy area.
This implies a concentration of planning specialists with tacit and explicit knowledge
about this subject at the (central) planning level. It will also put high requirements on
their communication skills.
)XWXUHGLUHFWLRQVRIUHVHDUFK
The general concern for health planners of course is the question “How should a health-
care system be organised and financed to meet the ends of the general public”? In general
in economics, the transaction cost economics approach offers a potential fruitful avenue
to discuss this subject (c.f. Williamson, 1975, 1986, 1995; Alexander, 1992). This theory
states that depending on a set of critical dimensions of a transaction between parties a
specific governance system will be chosen: the market, an individual organisation or a
hybrid form. Whether a particular transaction is allocated to one of these governance
systems is a matter of (transaction) cost minimisation. This approach emphasises that
transaction costs (costs of market transactions or costs of internal
transactions/management systems) should be taken into account. To make use of
transaction cost economics in the healthcare sector, it is necessary to translate it in
relevant healthcare sector terminology. The relevant governance forms would be a
national planning system (e.g. the national healthcare system of the UK) versus the
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market form (e.g. US-system) and in-between (intermediate) forms (e.g. Dutch-system)
(c.f. Hurst, 1992). The most critical dimension of a transaction is asset specificity. Asset
specificity has reference to the degree to which an asset can be redeployed to alternative
uses and by alternative users without sacrifice of productive value (Williamson, 1996). In
the field of radiotherapy asset specificity comes especially forward in human-asset
specificity (e.g. radiotherapists) and capital intensive infrastructure (equipment and
buildings). The effectiveness of their use is based on a high level of sub-specialisation.
Their use is essentially single purpose, the treatment of cancer patients. We expect that
co-ordination of planning and decision making regarding these kinds of assets, in the way
as indicated above, may result in the best possible utilisation of existing or new capacity.
This way of co-ordination resembles mostly an intermediate (hybrid) form of governance,
from a macro point of view. To get a real picture of the advantages and disadvantages of
the various governance forms in the field of radiotherapy, these should be systematically
compared (e.g. US-vs.-UK-vs.-Netherlands) on a range of indicators. This, however, asks
for systematic comparative research, which might be part of future research. One recent
signal that indicates a drawback of the increasing market-orientation of the Dutch
healthcare system is the rise of waiting lists for radiotherapy patients (NRC, July 25
2000). Also, to this aim the term transaction costs needs another specification. Indirect
costs of a healthcare system may be a proxy for transaction costs. This means that
insights are necessary into the indirect costs of hospitals and the health sector to make
comparisons. The introduction of accounting methods like Activity Based Costing may
enhance the possibilities to get insight into the indirect (overhead) costs of hospitals
(Cooper et. al., 1992). However, most hospitals don’t use these kinds of accounting
systems (c.f. Van der Pluijm, 1998). Also, information about indirect costs related to the
management/planning function for the healthcare sector as a whole is not available on the
needed level of detail. This approach will be subject of future research.
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&RQFOXGLQJUHPDUNV
The political discourse on health planning has focused on seemingly contrasts or
antitheses, such as centralisation versus decentralisation, cure versus care, individual
versus population, and regulation versus competition (Rodwin, 1984). Black (1984)
shows clearly that these kinds of antitheses in healthcare are not always fruitful or - even
worse -  can be false. Centralised decision making and co-ordination at the macro level
that involves activities of all relevant participants or parties in fact also must involve
efforts and initiatives from decentralised levels (top down and bottom-up). A clear
balance needs to be arrived between these various decision making and planning levels.
In the Netherlands, advisory boards like the Health Council in principle can play an
intermediate and directing role between the different parties and their interests. This is
also one of the strengths of the Dutch ‘poldermodel’. This model implies a co-ordination
based on checks and balances, resulting in consensus between different parties at
different decision making/planning levels. In Williamson’s words this kind of co-
ordination suggests a hybrid kind of solution. This means that the intermediate co-
ordinating bodies voluntarily interact, consult, or negotiate with each other to arrive at
suggestions or solutions (preferably consensus) with more or less compulsory outcomes.
This rather strong position of these intermediate bodies, however, does not preclude that
the Minister of Healthcare must be decision maker of last resort (as stated in section 2).
This also characterises the typical Dutch situation. An element that may be relevant in
this discussion is that because of the sheer size of the Netherlands the co-ordination of
strategic decision processes can be organised country-wide in this way. For larger
countries, for instance the UK or the US, this way of interaction, however, may not work
out. In larger countries the transaction costs of dealing with each other, compared to the
Netherlands, may rise as a consequence of decreasing economies of scale. This indicates
that there may be a natural borderline between the various ways of organising strategic
decision making and planning processes. Also, differences in the preference (based on
historical, political, institutional, and governmental conditions) for a market-based co-
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ordination versus co-ordination based on discussion, consensus, or negotiation may play a
role in this respect.
With hindsight till the nineties the strategic decision making and planning of the
capacity and needs of healthcare facilities in the Netherlands can be characterised as
centrally directed decision making and co-ordination. From the early nineties a more
decentralised (market) and sometimes fragmented picture shows up, where the central
government acts as a financier and regulator of the healthcare system. In the field of
radiotherapy the continued pivotal role of the Health Council and Council for Hospital
Facilities as a link between different decision and planning bodies will pay off in the
future. Nowadays the gap between the needs for radiotherapy and the facilities available
in the Netherlands is widening resulting in waiting lists even for cancer patients.
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The capacity model accounts for the following variables, calculation rules, and
assumptions:
1. The number of new patients (NP) that gets cancer for the first time in a certain year
Ti is the function of demographic developments (Dem.), the (expected) cancer
incidence (Inc) for that year, and developments in the field of diagnostics and
treatment.
2. The percentage of new cancer patients (a) treated with radiotherapy (NPR) can vary,
according to technological developments and developments in the field of diagnostics
and treatment. NPR = a  x NP.
3. To take into account non-melanoma skin cancer and benign tumours, a percentage (b)
of NPR must be added to NPR. NPRincl. = (1 + b) NPR.
4. A percentage (c) of the number of this group of irradiated new patients will receive in
the same year an extra treatment This results in the corrected number of irradiated
new patients: NPRC = (1 + c) x NPRincl.
5. A fraction of the number of corrected irradiated new patients will receive
megavoltage  treatment. The number of megavoltage patients: NPM = d x NPRC.
6. Assuming that each radiotherapist can handle an annual workload of on average P
new radiotherapy patients, the needed number of radiotherapists in a certain year:
RT = NPRC/P.
7. Assuming that each radiophysicist can handle an annual workload of on average F
megavoltage patients, the needed number of radiophysicists in a certain year:
RP = NPRC/F.
8. Assuming that per megavolt patient on average S radiation treatment sessions are
required, the total number of radiation treatment sessions is:  TR = NPM x S.
9. Assuming that each radiotherapy technician can handle an annual workload of on
average N treatment sessions, the needed number of radiotherapy technicians in a
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certain year: RP = TR/N. (included also a correction factor of 0.8 for other activities:
RLf)
10. Assuming that a linear accelerator has a capacity or annual workload of U radiation




                                                          
1
 Law of Hospital Facilities (in Dutch: Wet Ziekenhuisvoorzieningen). This law gave the
Council for Hospital Facilities (in Dutch: College voor Ziekenhuisvoorzieningen) an
important role in the allocation of capital intensive medical technologies.
2
 Radiotherapy departments often differ in their capabilities to treat various groups of
cancer patients.
3
 It should be noted that the costs of radiotherapy are closely related to the cost of surgery
and internal medicine in cancer care. For instance the development of intra operative
radiotherapy, in which an operated patient receives local radiotherapy, leads to a rise of
both surgery and radiotherapy. A combined treatment of internal medicine and
radiotherapy also has combined cost repercussions.
4
 This section is largely based on HC, 1993
5
 This is an advisory board of the Dutch Cancer Foundation.
6
 SOOZ stands for Co-operative Association Hospitals in Oncology (Dutch). The SOOZ
involves 10 community hospitals in south-east Netherlands. The registry of about 25000
km2, comprises about 1 million inhabitants or 7% of the Dutch population (Coebergh,
1991).
7
 Also educational differences and access of patients to specialised knowledge in this field
might contribute to referral differences.
8
 In our opinion this is an advantage that is not very well recognised by Frissen and Van
der Meeren (2000), who only discuss the negative aspects and connotations of centralised
planning, suggesting that this resembles too much the ancient Soviet planning model.
